Literature DB >> 11232363

Hepatocyte transplantation. Advancing biology and treating children.

V L Ng1, M Alonso, J A Bezerra.   

Abstract

Key advances over the past three decades have allowed the evolution of hepatocyte transplantation from its use as an experimental tool to study liver cell biology to the initial application as a potential treatment modality for patients with liver disease. Although little is known about the cellular and molecular mechanisms regulating the fate of transplanted cells, studies in animal models of liver disease clearly suggest that transplanted hepatocytes have the potential to repopulate diseased livers and correct metabolic defects. Based on these experiments, human hepatocytes have been used in the treatment of children and adults with metabolic disease and liver failure. In initial trials, the improved clinical course following hepatocyte transplantation points to a potential role of the technique as an adjunct to liver transplantation.

Entities:  

Mesh:

Year:  2000        PMID: 11232363     DOI: 10.1016/s1089-3261(05)70147-1

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  2 in total

Review 1.  Liver transplantation for non-hepatotoxic inborn errors of metabolism.

Authors:  William R Treem
Journal:  Curr Gastroenterol Rep       Date:  2006-06

2.  Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.

Authors:  Jochen Meyburg; Thomas Opladen; Ute Spiekerkötter; Andrea Schlune; Jens-Peter Schenk; Jan Schmidt; Jürgen Weitz; Jürgen Okun; Friederike Bürger; Tawfeg Ben Omran; Ghassan Abdoh; Hilal Al Rifai; Ahmad Monavari; Vassiliki Konstantopoulou; Stefan Kölker; Marc Yudkoff; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2017-10-12       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.